Glaucoma Eye Clinical Trials
2 recruiting trials for Glaucoma Eye. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Glaucoma Eye clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hospices Civils de Lyon (1), Washington University School of Medicine (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is NEI-VFQ-25 (National Eye Institute Visual Function Questionnaire-25). (other, 1 trial), followed by Standard Implantation, Tied off Tube.
Track Glaucoma Eye trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
Glaucoma surgery currently relies on a wide therapeutic arsenal, ranging from conventional filtering surgeries to minimally invasive glaucoma surgery (MIGS). These techniques...
Tied Tube Trial in Glaucoma Surgery
The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Glaucoma Eye, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Glaucoma Eye, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Glaucoma Eye, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.